Yi Larson - 14 Jun 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: Director
Signature: /s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol: OLMA
Transactions as of: 14 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 18 Jun 2024, 17:00:21 UTC
Previous filing: 27 Feb 2024
Next filing: 13 Jun 2025
SEC: View on sec.gov

Key filing fact

Yi Larson filed Form 4 for Olema Pharmaceuticals, Inc. (OLMA) on 18 Jun 2024.

Key facts

This page summarizes Yi Larson's Form 4 filing for Olema Pharmaceuticals, Inc. (OLMA).
1 reported transaction and 1 derivative row are listed below.
Filing timestamp: 18 Jun 2024, 17:00.

Change

Previous filing in this sequence was filed on 27 Feb 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

OLMA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +23,000
Change %
Price: $0.000000
Shares after: 23,000
Date: 14 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,000
Exercise price: $12.36
Footnotes: F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 14, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.

Content

The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 14, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.